Cheyne Capital Management (UK)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-50,000
| Closed | -$407K | – | 42 |
|
|
2019
Q1 | $407K | Hold |
50,000
| – | – | 0.38% | 32 |
|
|
2018
Q4 | $404K | Sell |
50,000
-50,000
| -50% | -$404K | 0.38% | 33 |
|
|
2018
Q3 | $763K | Hold |
100,000
| – | – | 0.45% | 35 |
|
|
2018
Q2 | $573K | Hold |
100,000
| – | – | 0.41% | 32 |
|
|
2018
Q1 | $477K | Buy |
+100,000
| New | +$477K | 0.22% | 32 |
|